Diagonal Therapeutics

Developer of antibody therapeutics for the treatment of rare diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2022 language diagonaltx.com

Social engagement

Social engagement: 6K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include VF Partners, Atlas Venture, Sanofi Ventures, Janus Henderson Investors.

Investor typeCountShare
Venture capital950%
Private equity211%
Bank & private debt16%
Other / undisclosed633%

Recent activity

1 Jun 2026
Event
PVRI Symposium: Genetics-inspired Therapeutics for Pulmonary Hypertension
28 May 2026
Event
Jefferies Global Healthcare Conference
5 May 2026
Leadership hire
Chief Financial Officer
Coming soon